Sevillano Fernández, E.; Madurga de Lacalle, R.; Rodriguez Moreno, J.F.; BarquÃn GarcÃa, A.; Yagüe Fernández, M.; Navarro Alcaraz, P.; Barba Llacer, M.; Quiralte Pulido, M.; GarcÃa-Donás Jiménez, J.
Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients. J. Clin. Med. 2022, 11, 4483.
https://doi.org/10.3390/jcm11154483
AMA Style
Sevillano Fernández E, Madurga de Lacalle R, Rodriguez Moreno JF, BarquÃn GarcÃa A, Yagüe Fernández M, Navarro Alcaraz P, Barba Llacer M, Quiralte Pulido M, GarcÃa-Donás Jiménez J.
Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients. Journal of Clinical Medicine. 2022; 11(15):4483.
https://doi.org/10.3390/jcm11154483
Chicago/Turabian Style
Sevillano Fernández, Elena, Rodrigo Madurga de Lacalle, Juan Francisco Rodriguez Moreno, Arantzazu BarquÃn GarcÃa, Mónica Yagüe Fernández, Paloma Navarro Alcaraz, MarÃa Barba Llacer, Miguel Quiralte Pulido, and Jesús GarcÃa-Donás Jiménez.
2022. "Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients" Journal of Clinical Medicine 11, no. 15: 4483.
https://doi.org/10.3390/jcm11154483
APA Style
Sevillano Fernández, E., Madurga de Lacalle, R., Rodriguez Moreno, J. F., BarquÃn GarcÃa, A., Yagüe Fernández, M., Navarro Alcaraz, P., Barba Llacer, M., Quiralte Pulido, M., & GarcÃa-Donás Jiménez, J.
(2022). Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients. Journal of Clinical Medicine, 11(15), 4483.
https://doi.org/10.3390/jcm11154483
